ZYLö THERAPEUTICS
Zylö Therapeutics offers an innovative sustained-release drug-delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented hydrogel-derived nanoparticles, called Nanopods, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agents through topical administration. The company was founded in 2017 and is based in Greenville, South Carolina.
ZYLö THERAPEUTICS
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2017-11-01
Address:
Greenville, South Carolina, United States
Country:
United States
Website Url:
http://www.zylotherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
858.775.6710
Email Addresses:
[email protected]
Total Funding:
13.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Google GStatic Google Static Content Google Cloud
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
New York Angels
New York Angels investment in Series B - Zylö Therapeutics
James Cordes
James Cordes investment in Series B - Zylö Therapeutics
Harvard Business School Alumni Angels of Greater NY
Harvard Business School Alumni Angels of Greater NY investment in Series B - Zylö Therapeutics
Cowtown Angels
Cowtown Angels investment in Series B - Zylö Therapeutics
SC Launch, Inc.
SC Launch, Inc. investment in Series B - Zylö Therapeutics
Boston Harbor Angels
Boston Harbor Angels investment in Series B - Zylö Therapeutics
VentureSouth
VentureSouth investment in Series B - Zylö Therapeutics
SC Launch, Inc.
SC Launch, Inc. investment in Grant - Zylö Therapeutics
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Zylö Therapeutics
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Zylö Therapeutics
Official Site Inspections
http://www.zylotherapeutics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
